WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005063234) USE OF AT LEAST ONE EFFECTOR OF GLUTATHIONE METABOLISM, TOGETHER WITH ALPHA-LIPONIC ACID FOR THE TREATMENT OF LUNG DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/063234    International Application No.:    PCT/EP2004/014687
Publication Date: 14.07.2005 International Filing Date: 23.12.2004
Chapter 2 Demand Filed:    12.07.2005    
IPC:
A61K 31/137 (2006.01), A61K 31/20 (2006.01), A61K 31/366 (2006.01), A61K 45/06 (2006.01)
Applicants: ESPARMA GMBH [DE/DE]; Lange Göhren 3, 39171 Osterweddingen (DE) (For All Designated States Except US).
IMTM GMBH [DE/DE]; Leipziger Strasse 44, 39104 Magdeburg (DE) (For All Designated States Except US).
ANSORGE, Siegfried [DE/DE]; (DE) (For US Only).
KOEGST, Dieter [DE/DE]; (DE) (For US Only).
TÄGER, Michael [DE/DE]; (DE) (For US Only).
FRIES, Gerhard [DE/DE]; (DE) (For US Only)
Inventors: ANSORGE, Siegfried; (DE).
KOEGST, Dieter; (DE).
TÄGER, Michael; (DE).
FRIES, Gerhard; (DE)
Agent: PFENNING, MEINIG & PARTNER GBR; Patent- und Rechtsanwälte, Theresienhöhe 13, 80339 München (DE)
Priority Data:
103 60 954.7 23.12.2003 DE
Title (DE) VERWENDUNG EINES EFFEKTOR DES GLUTATHIONMETABOLISMUS ZUSAMMEN MIT &agr;-LIPONSÄURE ZUR BEHANDLUNG VON LUNGENERKRANKUNGEN
(EN) USE OF AT LEAST ONE EFFECTOR OF GLUTATHIONE METABOLISM, TOGETHER WITH ALPHA-LIPONIC ACID FOR THE TREATMENT OF LUNG DISEASES
(FR) UTILISATION D'AU MOINS UN EFFECTEUR DU METABOLISME DE GLUTATHIONE EN COMBINAISON AVEC UN ACIDE $G(A)-LIPONIQUE POUR LE TRAITEMENT DE MALADIES PULMONAIRES OBSTRUCTIVES CHRONIQUES
Abstract: front page image
(DE)Die vorliegende Erfindung betrifft die Verwendung von mindestens einem Effektor des Glutathionmetabolismus zusammen mit &agr;-Liponsäure, deren Salze und/oder deren Prodrugs zur gleichzeitigen, getrennten oder zeitlich abgestuften zytoprotektiven Behandlung chronisch obstruktiver Lungenerkrankungen.
(EN)The invention relates to the use of at least one effector of glutathione metabolism, together alpha liponic acid, the salts and/or prodrugs thereof for simultaneous or timed cytoprotective treatment of chronically obstructive lung diseases.
(FR)L'invention concerne l'utilisation d'au moins un effecteur du métabolisme de glutathione en combinaison avec un acide $g(a)-liponique, les sels et/ou les promédicaments de cet acide, pour le traitement cytoprotecteur simultané, séparé ou décalé en temps de maladies pulmonaires obstructives chroniques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)